Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease

European Heart Journal

Volumn 21, Issue 7, 2000, Pages 515-520

  Danesh, J ^a   Collins, R ^a   Peto, R ^a   Lowe, G D O ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Coronary heart disease; Haematocrit; Meta analysis; Rheology; Viscosity

Indexed keywords

BLOOD RHEOLOGY; BLOOD VISCOSITY; CLINICAL TRIAL; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; PLASMA VISCOSITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BLOOD SEDIMENTATION; BLOOD VISCOSITY; CORONARY DISEASE; HEMATOCRIT; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034016476     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1699     Document Type: Review

References (37)

1. Lowe G.D.O. Haemostatic risk factors for arterial and venous thrombosis. Poller L., Ludlam C.A., Recent advances in blood coagulation. 1997;69 Churchill Livingstone, Edinburgh.
2. Lowe G.D.O. Blood rheology, haemostasis and vascular disease. Bloom A.L., Forbes C.D., Thomas D.P., Tuddenham E.G.D., Haemostasis and thrombosis. 1994;1169-1188 Churchill Livingstone, Edinburgh:
3. Pearson T.C. Rheology of the absolute polycythaemias. Balliere's Clinical Haematology. 1:1987;637-664.
4. Wannamethee G., Shaper A.G., Whincup P.H. Ischaemic heart disease: association with haematocrit in the British Regional Heart Study. J Epidemiol Comm Health. 48:1994;112-118.
5. Liao Y., Cooper R.S., McGee D.L. Iron status and coronary heart disease: negative findings from the NHANES I follow-up study. Am J Epidemiol. 139:1994;704-712.
6. Rumley A., Lowe G.D.O., Norrie J., Ford I., Shepherd J., Cobbe S.M. Blood rheology and outcome in the west of Scotland coronary prevention study: is the benefit of lipoprotein reduction partly due to the lower viscosity. Br J Haematol. 97:1997;78.
7. Abu-Zeid H.A.H., Chapman J.M. The relation between hemoglobin level and the risk for ischemic heart disease: a prospective study. J Chron Dis. 29:1976;395-403.
8. Gagnon D.R., Zhang T.J., Brand F.N., Kannel W.B. Hematocrit and the risk of cardiovascular disease-the Framingham study: a 34-year follow-up. Am Heart J. 127:1994;674-682.
9. Reunanen A., Takkunen H., Knekt P., Seppanen R., Aromaa A. Body iron stores, dietary iron intake and coronary heart disease mortality. J Int Med. 238:1995;223-230.
10. Carter C., McGee D., Reed D., Yano K., Stemmermann M.D. Hematocrit and the risk of coronary heart disease: the Honolulu Heart Program. Am Heart J. 105:1983;674-679.
11. Sorlie P.D., Garcia-Palmieri M.R., Costas R., Havlik R.J. Hematocrit and risk of coronary heart disease: the Puerto Rico Heart Health Program. Am Heart J. 101:1981;456-461.
12. Meade T.W., Ruddock V., Stirling Y., Chakraborti R., Miller G.J. Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 342:1993;1076-1079.
13. Szatrowski T.P., Peterson A.V., Shimizu Y. Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort. J Chron Dis. 37:1984;569-584.
14. Erikssen G., Thaulow E., Sandvick L., Stormorken H., Erikssen J. Haematocrit: a predictor of cardiovascular mortality. J Intr Med. 234:1993;493-499.
15. Campbell M.J., Elwood P.C., Mackean J., Waters W.E. Mortality, haemoglobin level and haematocrit in women. J Chron Dis. 38:1985;881-889.
16. Lowe G.D.O., Lee A.J., Rumley A., Price J.F., Fowkes F.G.R. Blood viscosity and risk of cardiovascular events: the Edinburgh artery study. Br J Haematol. 96:1997;168-173.
17. Cullen K., Stenhouse N.S., Wearne K.L., Welborn T.A. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia - 13-year study. J Chron Dis. 36:1983;371-377.
18. Cullen K.J., Stenhouse N.S., Wearne K.L. Raised haemoglobin and risk of cardiovascular disease. Lancet. ii:1981;1288-1289.
19. Knottnerus J.A., Swaen G.M.H., Slangen J.J.M., Volovics A., Durinck J. Haematologic parameters as risk factors for cardiac infarction in an occupational health care setting. J Clin Epidemiol. 41:1988;67-74.
20. Elwood P.C., Benjamin I.T., Waters W.E., Sweetnam P.M. Mortality and anaemia in women. Lancet. i:1974;891-894.
21. Schlant R.C., Forman S., Stamler J., Canner P.L. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. Circulation. 66:1982;401-414.
22. Lowe G.D.O., Machado S.G., Krol W.F., Barton B.A., Forbes C.D. White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. Thromb Haemost. 54:1985;700-703.
23. Smith F.B., Rumley A., Lee A.J., Leng G.C., Fowkes F.G.R., Lowe G.D.O. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants. Br J Haematol. 100:1998;758-763.
24. Sweetnam P.M., Thomas H.F., Yarnell J.W.G., Beswick A.D., Baker I.A., Elwood P.C. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease: the Caerphilly and Speedwell studies. Eur Heart J. 17:1996;1814-1820.
25. Koenig W., Sund M., Filipiak B., Doring A., Lowel H., Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the Monica-Augsburg cohort study, 1984 to 1992. Arterioscler Thromb Vasc Biol. 18:1998;768-772.
26. Martin J.F., Bath P.M.W., Burr M.L. Influence of platelet size on outcome after myocardial infarction. Lancet. 338:1991;1409-1411.
27. Gillum R.F., Mussolino M.E., Makuc D.M. Erythrocyte sedimentation rate and coronary heart disease: the NHANES I epidemiologic follow-up study. J Clin Epidemiol. 48:1995;353-361.
28. Bottiger L.E., Carlson L.A. Risk factors for ischaemic vascular death for men in the Stockholm prospective study. Atherosclerosis. 36:1980;389-408.
29. Tibblin G., Wilhelmsen L., Werko L. Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiology. 35:1975;514-522.
30. Rafnsson V., Bengtsson C. Erythrocyte sedimentation rate and cardiovascular disease: results from a population study of women in Goteborg, Sweden. Atherosclerosis. 42:1982;97-107.
31. Danesh J., Collins R., Appleby P., Peto R. Fibrinogen, C-reactive protein, albumin or white cell count: meta-analyses of prospective studies of coronary heart disease. JAMA. 279:1998;1477-1482.
32. MacMahon S., Peto R., Cutler J. Blood pressure, stroke, and coronary heart disease-part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 335:1990;765-774.
33. Clarke R., Shipley M., Lewington S. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 150:1999;341-353.
34. Clin Hemorrheology. 6:1986;439-453.
35. Easterbrook P., Berlin J., Gopalan R., Matthews D. Publication bias in clinical research. Lancet. 337:1991;867-872.
36. Waters W.E., Withey J.L., Kilpatrick G.S., Wood P.H.N., Abernathy M. Ten-year haematological follow-up: mortality and haematological changes. BMJ. 4:1969;761-764.
37. Banerjee A.K., Pearson J., Gilliland E.L. A six year prospective study of fibrinogen and other risk factors associated with mortality in stable claudicants. Thromb Haemost. 68:1992;261-263.